DL-Isoleucine is a free, proteinogenic amino acid in the isoleucine class, featuring a branched aliphatic side chain attached to the alpha carbon and bearing both an amino group and a carboxyl group. As a DL racemate, it is present as an equimolar mixture of stereoisomers at the chiral center, and its side chain is predominantly hydrophobic with a secondary carbon substituent pattern characteristic of isoleucine. DL-Isoleucine is used as a defined amino acid building block for peptide synthesis and as a reference material in amino acid analysis, including chromatographic and derivatization-based workflows where racemic standards are required.
DL-Isoleucine is a branched-chain amino acid with a stereogenic center at the alpha carbon and a hydrophobic side chain featuring an isopropyl group, existing here as an equimolar mixture of D- and L-enantiomers. The molecule contains a free primary amino functionality and a carboxylic acid, enabling salt formation and straightforward conversion into N- and C-terminally addressable derivatives for peptide coupling. The zwitterionic character and side-chain hydrophobicity influence solubility, chromatographic behavior, and reactivity during protection, activation, and coupling steps. As a chiral amino acid starting material in racemic form, DL-Isoleucine can be transformed into protected amino acid derivatives, chiral intermediates, and downstream building blocks for peptide science, biochemical research, and industrial fine chemical synthesis.
1. Racemic Peptide Building Block
DL-Isoleucine is applied in peptide synthesis workflows where a racemic isoleucine residue is acceptable for library generation, method development, or non-stereospecific sequence construction. The alpha-amino and alpha-carboxyl groups can be converted into N-protected amino acid derivatives and activated carboxyl equivalents, supporting standard peptide coupling chemistry and enabling incorporation at either internal or terminal positions. The branched hydrophobic side chain provides consistent steric and conformational features that influence peptide folding propensity and chromatographic retention. Racemic incorporation can be used to generate diastereomeric mixtures for analytical method screening, peptide material characterization, or SAR-oriented studies where stereochemical resolution is performed downstream.
2. Chiral Resolution Intermediate
DL-Isoleucine serves as a practical feedstock for chiral synthesis strategies that require access to isoleucine stereochemistry through resolution or stereoselective transformation. The presence of a defined alpha stereocenter in a racemate allows downstream formation of diastereomeric salts or derivatives with chiral auxiliaries, after which enantiomerically enriched isoleucine derivatives can be isolated for protected amino acid synthesis. The amino acid's functional group pattern supports conversion into N-protected forms and subsequent activation steps once the desired stereochemistry is obtained. The resulting enantiopure protected amino acid can feed into peptide building block preparation and stereochemically controlled peptidomimetic construction, linking racemic starting material handling to chiral intermediate production.
3. Amino Acid Derivatization Chemistry
DL-Isoleucine is utilized in synthetic organic chemistry and biochemical reagent development to generate functionalized amino acid derivatives through selective protection, activation, and side-chain-compatible transformations. The carboxylic acid can be esterified to tune solubility and reactivity, while the amino group can be protected to control chemoselectivity during multi-step syntheses. The hydrophobic isopropyl side chain can be retained while the backbone is manipulated, enabling preparation of activated esters, amides, and peptide coupling reagents that maintain the isoleucine framework. Downstream derivatization supports construction of amino acid-based intermediates for process chemistry, fine chemical synthesis, and analytical standards where consistent mass and fragmentation behavior are required.
4. Chemical Biology And Labeling
DL-Isoleucine can be applied in chemical biology research and analytical studies where incorporation of isoleucine analogs or amino acid-derived tags into peptides is used to probe molecular interactions. The amino acid backbone enables conversion into protected building blocks that can be coupled onto peptide scaffolds, while the racemic nature may be leveraged for generating stereochemical mixtures for method validation or binding assays that do not require enantiopure residues. Backbone functional group transformations, including N-protection and C-terminal activation, support conjugation-compatible intermediates for attaching probes, handles, or affinity tags. The resulting labeled or modified peptides can serve as substrates for biochemical assays, reference materials for LC-MS/MS method development, or standards for monitoring peptide synthesis and purification performance.
5. Pharmaceutical Intermediate Preparation
DL-Isoleucine is suitable for pharmaceutical intermediate preparation and industrial fine chemical synthesis routes that require amino acid-based building blocks for downstream manufacturing steps. The molecule's amino and carboxyl functionalities support conversion into protected amino acid derivatives, activated coupling partners, or ester/amide intermediates used in controlled sequence assembly. The branched hydrophobic side chain can influence crystallization behavior and solid-state properties of intermediates, which is relevant for scale-up where physical form control affects downstream processing. Racemic starting material can also be used where stereochemical enrichment occurs later in the route, enabling flexible supply of amino acid-derived intermediates for peptide-related manufacturing and specialty chemical production.
6. Industrial Biocatalysis Feedstock
DL-Isoleucine can be employed as a feedstock in industrial biocatalysis and process chemistry contexts where amino acid transformations are coupled to enzymatic steps. The alpha-amino acid structure supports enzymatic recognition in pathways that convert amino acids into activated derivatives, metabolites, or peptide precursors, while the racemic mixture can be processed through selective enzymatic steps to enrich one enantiomer. The carboxylate and amino groups enable formation of salts or protected intermediates that can be tuned for compatibility with biocatalyst operating conditions. Resulting enantiomer-enriched amino acid derivatives can then be directed into protected amino acid synthesis, peptide building block preparation, and downstream industrial manufacturing of amino acid-derived products.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More